=Moleculin Biotech (MBRX): collaboration with the University of Bergen

Moleculin Biotech enters into a collaborative agreement with the University of Bergen to test WP1122 in combination with the drug Avastin, made by Roche (RHHBY)

• Roche Pharma is not a party to the collaborative agreement.